Evidence map›Paper›PMID 37423621›Full record

ReviewBMJ global health2023

A narrative review of high-level isolation unit operational and infrastructure features.

Joseph Lukowski, Angela Vasa, Christa Arguinchona, Wael ElRayes, Maria G Frank, Alison L Galdys, Mary C Garcia, Jennifer A Garland, Susan Kline, Caroline Persson and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in BMJ global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Joseph LukowskiCollege of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID 0000-0001-7112-3591
Angela VasaNebraska Medicine, Omaha, Nebraska, USA.
Christa ArguinchonaSpecial Pathogens Program, Providence Sacred Heart Medical Center, Spokane, Washington, USA.
Wael ElRayesCollege of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Maria G FrankSchool of Medicine, University of Colorado, Denver, Colorado, USA.
Alison L GaldysDivision of Infectious Disease and International Medicine - Department of Medicine, University of Minnesota Medical School Twin Cities Campus, Minneapolis, Minnesota, USA.
Mary C GarciaDepartment of Laboratory Services, The University of Texas Medical Branch, Galveston, Texas, USA.
Jennifer A GarlandDepartment of Hospital Epidemiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Susan KlineDivision of Infectious Disease and International Medicine - Department of Medicine, University of Minnesota Medical School Twin Cities Campus, Minneapolis, Minnesota, USA.
Caroline PerssonBiocontainment Unit, Denver Health and Hospital Authority, Denver, Colorado, USA.
Darrell RubySpecial Pathogens Program, Providence Sacred Heart Medical Center, Spokane, Washington, USA.
Lauren M SauerCollege of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Sami VasisthaGlobal Center for Health Security, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Sharon CarrascoSerious Communicable Disease Program, Emory University, Atlanta, Georgia, USA.
Jocelyn J HersteinCollege of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA jocelyn.herstein@unmc.edu.
University of Nebraska Medical Center · USDenver Health Medical Center · USProvidence Sacred Heart Medical Center · USUniversity of Minnesota Medical Center · USCedars-Sinai Medical Center · USEmory University · USNebraska Medical Center · USThe University of Texas Medical Branch at Galveston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-level isolation units (HLIUs) are specially designed facilities for care and management of patients with suspected or confirmed high-consequence infectious diseases (HCIDs), equipped with unique infrastructure and operational features. While individual HLIUs have published on their experiences caring for patients with HCIDs and two previous HLIU consensus efforts have outlined key components of HLIUs, we aimed to summarise the existing literature that describes best practices, challenges and core features of these specialised facilities. A narrative review of the literature was conducted using keywords associated with HLIUs and HCIDs. A total of 100 articles were used throughout the manuscript from the literature search or from alternate methods like reference checks or snowballing. Articles were sorted into categories (eg, physical infrastructure, laboratory, internal transport); for each category, a synthesis of the relevant literature was conducted to describe best practices, experiences and operational features. The review and summary of HLIU experiences, best practices, challenges and components can serve as a resource for units continuing to improve readiness, or for hospitals in early stages of developing their HLIU teams and planning or constructing their units. The COVID-19 pandemic, a global outbreak of mpox, sporadic cases of viral haemorrhagic fevers in Europe and the USA, and recent outbreaks of Lassa fever, Sudan Ebolavirus, and Marburg emphasise the need for an extensive summary of HLIU practices to inform readiness and response.

Indexed as

Communicable DiseasesCOVID-19Hemorrhagic Fevers, ViralDisease OutbreaksHumansPandemicsControl strategiesEnvironmental healthHealth policyReviewViral haemorrhagic fevers

Identifiers

PMID37423621
PMCPMC10335574
OpenAlexW4383670153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.